XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Xencor Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$23.19+0.34 (+1.49%)
Close on Oct 19, 2026
- Market cap
- $1.76B
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
100.0%
84M of 74M shares
Institutional holders
208
33 new, 24 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 18 sales
Net sold $3.90M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Bvf Partners L P/Il | 7,133,720 | 9.99% | 13G (passive) amendment | Dec 31, 2025 |
| Roderick Wong | 6,221,054 | 8.70% | 13G (passive) | Sep 30, 2025 |
| Rajeev Shah | 4,736,739 | 6.50% | 13G (passive) | Mar 23, 2026 |
| EcoR1 Capital, LLC | 4,640,000 | 6.40% | 13G (passive) amendment | Dec 31, 2025 |
| Lampert Mark N | 4,619,341 | 6.50% | 13G (passive) | Oct 9, 2025 |
| State Street Corporation | 4,507,254 | 6.30% | 13G (passive) | Dec 31, 2025 |
| Vanguard Capital Management | 3,810,823 | 5.13% | 13G (passive) | Jun 30, 2026 |
| BlackRock, Inc. | 11,130,112 | 15.80% | 13G (passive) amendment | Mar 31, 2025 |
| Primecap Management Co/Ca/ | 10,527,322 | 14.79% | 13G (passive) amendment | Jun 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of XNCR | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 13,651,261 | 18.36% | $219.79M | +615,343 | 0.00% |
| Primecap Management Co/Ca/ | 10,181,322 | 13.69% | $163.92M | −156,700 | 0.10% |
| Bvf Inc/Il | 7,133,720 | 9.59% | $114.85M | – | 2.94% |
| Rtw Investments, LP | 6,777,461 | 9.12% | $109.12M | – | 0.93% |
| Ra Capital Management, L.P. | 5,274,274 | 7.09% | $84.92M | +377,037 | 0.74% |
| State Street Corp | 4,954,016 | 6.66% | $79.76M | +601,980 | 0.00% |
| Vanguard Capital Management LLC | 3,278,802 | 4.41% | $52.79M | +177,155 | 0.00% |
| TCG Crossover Management, LLC | 2,452,138 | 3.30% | $39.48M | – | 0.95% |
| Price T Rowe Associates Inc /Md/ | 2,356,409 | 3.17% | $37.94K | +795,989 | 0.00% |
| Vanguard Portfolio Management LLC | 2,215,690 | 2.98% | $35.67M | −1,284,652 | 0.00% |
| Geode Capital Management, LLC | 1,920,859 | 2.58% | $30.93M | +105,282 | 0.00% |
| Morgan Stanley | 1,752,556 | 2.36% | $28.22M | +194,266 | 0.00% |
| UBS Group AG | 1,306,174 | 1.76% | $21.03M | +223,755 | 0.00% |
| Baker Bros. Advisors LP | 1,102,106 | 1.48% | $17.74M | – | 0.09% |
| Legal & General Group Plc | 1,091,177 | 1.47% | $17.57M | +24,397 | 0.00% |
| Dimensional Fund Advisors LP | 1,011,119 | 1.36% | $16.28M | −283,768 | 0.00% |
| Goldman Sachs Group Inc | 968,778 | 1.30% | $15.60M | +204,985 | 0.00% |
| Millennium Management LLC | 853,677 | 1.15% | $13.74M | +243,889 | 0.00% |
| Two Sigma Investments, LP | 819,515 | 1.10% | $13.19M | +14,094 | 0.01% |
| Northern Trust Corp | 794,279 | 1.07% | $12.79M | +49,760 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 208 | 84M | 100.0% | 33 / 84 | 56 / 24 | 7M | 7M |
| Q1 2026 | 203 | 84M | 100.0% | 26 / 70 | 65 / 28 | 16M | 6M |
| Q4 2025 | 208 | 82M | 100.0% | 35 / 60 | 78 / 28 | 12M | 12M |
| Q3 2025 | 206 | 82M | 100.0% | 34 / 56 | 81 / 19 | 10M | 12M |
| Q2 2025 | 193 | 84M | 100.0% | 24 / 92 | 38 / 32 | 11M | 6M |
| Q1 2025 | 202 | 79M | 100.0% | 35 / 70 | 67 / 25 | 8M | 3M |
| Q4 2024 | 193 | 75M | 100.0% | 24 / 82 | 55 / 40 | 10M | 8M |
| Q3 2024 | 210 | 72M | 97.2% | 39 / 58 | 82 / 26 | 24M | 6M |
| Q2 2024 | 198 | 65M | 87.8% | 25 / 65 | 70 / 25 | 5M | 6M |
| Q1 2024 | 201 | 67M | 89.8% | 32 / 71 | 68 / 23 | 9M | 7M |
| Q4 2023 | 195 | 65M | 87.0% | 35 / 76 | 57 / 17 | 7M | 6M |
| Q3 2023 | 178 | 63M | 85.4% | 20 / 59 | 76 / 23 | 3M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of XNCR | Value | % of fund | As of |
|---|---|---|---|---|---|
| PRIMECAP Odyssey Aggressive Growth Fund | 6,335,377 | 8.52% | $128.04M | 1.73% | Jul 31, 2026 |
| iShares Core S&P Small-Cap ETF | 4,452,436 | 5.99% | $71.68M | 0.06% | Jun 30, 2026 |
| PRIMECAP Odyssey Growth Fund | 3,098,000 | 4.17% | $62.61M | 1.03% | Jul 31, 2026 |
| Vanguard Total Stock Market Index Fund | 2,341,988 | 3.15% | $37.71M | 0.00% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | 1,939,670 | 2.61% | $31.23M | 0.29% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,818,513 | 2.45% | $29.28M | 0.04% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 860,782 | 1.16% | $13.86M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 761,339 | 1.02% | $15.39M | 0.05% | Jul 31, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF | 683,023 | 0.92% | $11.00M | 0.07% | Jun 30, 2026 |
| iShares Russell 2000 Value ETF | 647,765 | 0.87% | $10.43M | 0.07% | Jun 30, 2026 |
| iShares S&P Small-Cap 600 Value ETF | 637,238 | 0.86% | $10.26M | 0.13% | Jun 30, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 634,300 | 0.85% | $10.21M | 0.07% | Jun 30, 2026 |
| Vanguard Explorer Fund | 592,179 | 0.80% | $11.97M | 0.05% | Jul 31, 2026 |
| BlackRock Advantage Small Cap Core Fund | 532,912 | 0.72% | $6.33M | 0.12% | May 29, 2026 |
| iShares Biotechnology ETF | 492,923 | 0.66% | $7.94M | 0.09% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Bassil I. Dahiyat | PRESIDENT & CEO, Director | 546,316 | 0.73% | Mar 9, 2026 |
| Bart Jan Cornelissen | SR. VICE PRESIDENT & CFO | 75,898 | 0.10% | Apr 13, 2026 |
| John R. Desjarlais | SR. VICE PRESIDENT & CSO | 263,831 | 0.35% | Mar 9, 2026 |
| Celia Eckert | SVP, GENERAL COUNSEL | 76,918 | 0.10% | Mar 9, 2026 |
| Nancy Valente | EVP, Chief Development Officer | 49,169 | 0.07% | May 6, 2025 |
| Barbara Klencke | Director | 29,974 | 0.04% | Jul 8, 2026 |
| Kevin Charles Gorman | Director | 21,680 | 0.03% | Jul 8, 2026 |
| Todd E. Simpson | Director | 23,988 | 0.03% | Jul 8, 2026 |
| Ellen Feigal | Director | 22,642 | 0.03% | Jul 8, 2026 |
| Alan Bruce Montgomery | Director | 25,849 | 0.03% | Jul 8, 2026 |
| Kurt A. Gustafson | Director | 25,011 | 0.03% | Jul 8, 2026 |
| Raymond Joseph Deshaies | Director | 10,302 | 0.01% | Jul 8, 2026 |
| Richard J. Ranieri | Director | 24,011 | 0.03% | Jul 8, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Ellen Feigal Director | Jun 18, 2026 | Sale(10b5-1 plan) | −6,843 | $13.06 | $89.37K | 12,340 |
| Todd E. Simpson Director | Jun 16, 2026 | Award | +10,302 | – | – | 23,988 |
| Ellen Feigal Director | Jun 16, 2026 | Award | +10,302 | – | – | 22,642 |
| Barbara Klencke Director | Jun 16, 2026 | Award | +10,302 | – | – | 29,974 |
| Richard J. Ranieri Director | Jun 16, 2026 | Award | +10,302 | – | – | 24,011 |
| Kevin Charles Gorman Director | Jun 16, 2026 | Award | +10,302 | – | – | 21,680 |
| Raymond Joseph Deshaies Director | Jun 16, 2026 | Award | +10,302 | – | – | 10,302 |
| Kurt A. Gustafson Director | Jun 16, 2026 | Award | +10,302 | – | – | 25,011 |
| Alan Bruce Montgomery Director | Jun 16, 2026 | Award | +10,302 | – | – | 25,849 |
| Alan Bruce Montgomery Director | Jun 15, 2026 | Sale(10b5-1 plan) | −5,064 | $12.31 | $62.34K | 15,547 |
| Kevin Charles Gorman Director | Jun 15, 2026 | Sale(10b5-1 plan) | −7,527 | $12.31 | $92.66K | 11,378 |
| Kurt A. Gustafson Director | Jun 15, 2026 | Sale(10b5-1 plan) | −5,474 | $12.31 | $67.38K | 14,709 |
| Richard J. Ranieri Director | Jun 15, 2026 | Sale(10b5-1 plan) | −5,474 | $12.31 | $67.38K | 13,709 |
| Bart Jan Cornelissen SR. VICE PRESIDENT & CFO | Apr 10, 2026 | Sale | −3,499 | $12.29 | $43.00K | 75,898 |
| John R. Desjarlais SR. VICE PRESIDENT & CSO | Mar 6, 2026 | Sale | −2,502 | $11.02 | $27.57K | 263,831 |
| Bassil I. Dahiyat PRESIDENT & CEO, Director | Mar 6, 2026 | Sale | −6,606 | $11.02 | $72.80K | 546,316 |
| Celia Eckert SVP, GENERAL COUNSEL | Mar 6, 2026 | Sale | −1,767 | $11.02 | $19.47K | 76,918 |
| John R. Desjarlais SR. VICE PRESIDENT & CSO | Mar 5, 2026 | Sale | −4,118 | $11.25 | $46.33K | 266,333 |
| Bassil I. Dahiyat PRESIDENT & CEO, Director | Mar 5, 2026 | Sale | −14,870 | $11.25 | $167.29K | 552,922 |
| Celia Eckert SVP, GENERAL COUNSEL | Mar 5, 2026 | Sale | −3,244 | $11.25 | $36.50K | 78,685 |
| Bart Jan Cornelissen SR. VICE PRESIDENT & CFO | Mar 5, 2026 | Sale | −2,517 | $11.25 | $28.32K | 79,397 |
| Bassil I. Dahiyat PRESIDENT & CEO, Director | Mar 3, 2026 | Sale | −6,758 | $11.90 | $80.42K | 567,792 |
| Celia Eckert SVP, GENERAL COUNSEL | Mar 3, 2026 | Sale | −1,492 | $11.90 | $17.75K | 81,929 |
| John R. Desjarlais SR. VICE PRESIDENT & CSO | Mar 3, 2026 | Sale | −2,663 | $11.90 | $31.69K | 270,451 |
| Bassil I. Dahiyat PRESIDENT & CEO, Director | Mar 2, 2026 | Award | +97,291 | – | – | 574,550 |
| Celia Eckert SVP, GENERAL COUNSEL | Mar 2, 2026 | Award | +18,680 | – | – | 83,421 |
| John R. Desjarlais SR. VICE PRESIDENT & CSO | Mar 2, 2026 | Award | +24,907 | – | – | 273,114 |
| Bart Jan Cornelissen SR. VICE PRESIDENT & CFO | Mar 2, 2026 | Award | +19,458 | – | – | 81,914 |
| John R. Desjarlais SR. VICE PRESIDENT & CSO | Jan 23, 2026 | Option exercise | +5,322 | $12.51 | $66.58K | 248,207 |
| Bassil I. Dahiyat PRESIDENT & CEO, Director | Dec 22, 2025 | Option exercise | +10,624 | $12.51 | $132.91K | 477,259 |
| John R. Desjarlais SR. VICE PRESIDENT & CSO | Dec 22, 2025 | Option exercise | +6,311 | $12.51 | $78.95K | 242,885 |
| Bassil I. Dahiyat PRESIDENT & CEO, Director | Dec 19, 2025 | Option exercise | +114,377 | $12.51 | $1.43M | 581,012 |
| Bassil I. Dahiyat PRESIDENT & CEO, Director | Dec 19, 2025 | Sale | −114,377 | $15.71 | $1.80M | 466,635 |
| John R. Desjarlais SR. VICE PRESIDENT & CSO | Dec 19, 2025 | Option exercise | +73,367 | $12.51 | $917.82K | 309,941 |
| John R. Desjarlais SR. VICE PRESIDENT & CSO | Dec 19, 2025 | Sale | −73,367 | $15.72 | $1.15M | 236,574 |
| Ellen Feigal Director | Jun 16, 2025 | Sale(10b5-1 plan) | −2,993 | $9.22 | $27.60K | 19,183 |
| Richard J. Ranieri Director | Jun 16, 2025 | Sale(10b5-1 plan) | −2,993 | $9.22 | $27.60K | 19,183 |
| Kurt A. Gustafson Director | Jun 16, 2025 | Sale(10b5-1 plan) | −2,993 | $9.22 | $27.60K | 20,183 |
| Kevin Charles Gorman Director | Jun 16, 2025 | Sale(10b5-1 plan) | −3,173 | $9.22 | $29.26K | 18,905 |
| Alan Bruce Montgomery Director | Jun 16, 2025 | Sale(10b5-1 plan) | −2,215 | $9.22 | $20.42K | 20,611 |
| Ellen Feigal Director | Jun 12, 2025 | Award | +13,686 | – | – | 22,176 |
| Richard J. Ranieri Director | Jun 12, 2025 | Award | +13,686 | – | – | 22,176 |
| Barbara Klencke Director | Jun 12, 2025 | Award | +13,686 | – | – | 19,672 |
| Todd E. Simpson Director | Jun 12, 2025 | Award | +13,686 | – | – | 13,686 |
| Kurt A. Gustafson Director | Jun 12, 2025 | Award | +13,686 | – | – | 23,176 |
| Kevin Charles Gorman Director | Jun 12, 2025 | Award | +13,686 | – | – | 22,078 |
| Alan Bruce Montgomery Director | Jun 12, 2025 | Award | +13,686 | – | – | 22,826 |
| Nancy Valente EVP, Chief Development Officer | May 2, 2025 | Sale | −4,616 | $11.03 | $50.91K | 49,169 |
| Bart Jan Cornelissen SR. VICE PRESIDENT & CFO | Apr 10, 2025 | Sale | −3,750 | $8.06 | $30.23K | 61,348 |
| Nancy Valente EVP, Chief Development Officer | Mar 10, 2025 | Sale | −2,565 | $13.60 | $34.88K | 53,785 |
| John R. Desjarlais SR. VICE PRESIDENT & CSO | Mar 10, 2025 | Sale | −9,697 | $13.60 | $131.88K | 236,574 |
| Bassil I. Dahiyat PRESIDENT & CEO, Director | Mar 10, 2025 | Sale | −19,716 | $13.60 | $268.14K | 465,419 |
| Celia Eckert SVP, GENERAL COUNSEL | Mar 10, 2025 | Sale | −5,740 | $13.60 | $78.06K | 63,507 |
| John R. Desjarlais SR. VICE PRESIDENT & CSO | Mar 4, 2025 | Award | +29,851 | – | – | 246,271 |
| Bassil I. Dahiyat PRESIDENT & CEO, Director | Mar 4, 2025 | Award | +109,745 | – | – | 485,135 |
| Bart Jan Cornelissen SR. VICE PRESIDENT & CFO | Mar 4, 2025 | Award | +21,949 | – | – | 65,098 |
| Celia Eckert SVP, GENERAL COUNSEL | Mar 4, 2025 | Award | +21,949 | – | – | 69,247 |
| Bassil I. Dahiyat PRESIDENT & CEO, Director | Feb 3, 2025 | Option exercise | +8,808 | $15.69 | $138.20K | 375,390 |
| John R. Desjarlais SR. VICE PRESIDENT & CSO | Feb 3, 2025 | Option exercise | +3,542 | $15.69 | $55.57K | 216,420 |
| Alan Bruce Montgomery Director | Dec 4, 2024 | Sale(10b5-1 plan) | −1,421 | $27.03 | $38.41K | 9,140 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Ellen Feigal Director | Jun 18, 2026 | 6,843 | $89.37K | Jun 18, 2026 | Restricted Stock Vesting |
| Alan Bruce Montgomery Director | Jun 15, 2026 | 5,064 | $62.34K | Jun 15, 2026 | Restricted Stock Vesting |
| Richard J. Ranieri Director | Jun 15, 2026 | 5,474 | $67.38K | Jun 15, 2026 | Restricted Stock Vesting |
| Kurt A. Gustafson Director | Jun 15, 2026 | 5,474 | $67.38K | Jun 15, 2026 | Restricted Stock Vesting |
| Kevin Charles Gorman Director | Jun 15, 2026 | 7,527 | $92.66K | Jun 15, 2026 | Restricted Stock Vesting |
| Bart Jan Cornelissen Officer | Apr 10, 2026 | 3,499 | $42.99K | Apr 10, 2026 | Restricted Stock Vesting |
| Celia Eckert Officer | Mar 6, 2026 | 1,767 | $19.47K | Mar 6, 2026 | Restricted Stock Vesting |
| Bassil I. Dahiyat Officer, Director | Mar 6, 2026 | 6,606 | $72.80K | Mar 6, 2026 | Restricted Stock Vesting |
| John R. Desjarlais Officer | Mar 6, 2026 | 2,502 | $27.57K | Mar 6, 2026 | Restricted Stock Vesting |
| Celia Eckert Officer | Mar 5, 2026 | 3,244 | $36.48K | Mar 5, 2026 | Restricted Stock Vesting |
| Bassil I. Dahiyat Officer, Director | Mar 5, 2026 | 14,870 | $167.22K | Mar 5, 2026 | Restricted Stock Vesting |
| Bart Jan Cornelissen Officer | Mar 5, 2026 | 2,517 | $28.30K | Mar 5, 2026 | Restricted Stock Vesting |
| John R. Desjarlais Officer | Mar 5, 2026 | 4,118 | $46.31K | Mar 5, 2026 | Restricted Stock Vesting |
| Bassil I. Dahiyat Officer, Director | Mar 3, 2026 | 6,758 | $80.39K | Mar 3, 2026 | Restricted Stock Vesting |
| Celia Eckert Officer | Mar 3, 2026 | 1,492 | $17.75K | Mar 3, 2026 | Restricted Stock Vesting |